References
- Pedersen-Bjergaard J, Christiansen DH, Andersen M, Skovby F. Causality of myelodysplasia and acute myeloid leukemia and their genetic abnormalities. Leukemia 2002;16:2177 -2184.
- Felix CA. Leukemias related to treatment with DNA topoisomerase inhibitors. Med Pediatr Oncol 2001;36:525 -535.
- Patte C, Auperin A, Michon J et al. The Societe Francaise d’Oncologie Pediatrique LMB89 protocol: highly effective multiagent chemotherapy tailored to the tumor burden and initial response in 561 unselected children with B-cell lymphomas and L3 leukemia. Blood 2001;97:3370 - 3379.
- Reiter A, Schrappe M, Tiemann M et al. Improved treatment results in childhood B-cell neoplasms with tailored intensification of therapy: a report of the Berlin - Frankfurt - Munster group trial NHL-BFM. Blood 1999;94:3294 - 3306.